Intellectual Property, Ethics and the Market

in the Era of Personalised Medicine

 

Tsuzuki Lecture Theatre, Ruth Deech Building,

St Anne’s College, Oxford

12-13 June 2017

 

Conference Programme

 Day 1

 12.30 – 13.00             Registration and tea / coffee

 Afternoon Session 1 Chair Dr Katerina Sideri

 13.00 – 13.05              Professor Simon Leedham Welcome

 13.05 – 13.55              Professor Graham Dutfield Expanding the scope of patentability for Personalised Medicine: Have we gone too far?

 13.55 – 14.45              Professor Shobita Parthasarathy Patent politics: Life forms, markets and the public interest in the United States

 14.45 – 15.10             Tea / coffee break

  Afternoon Session 2 Chair Professor Cecilia Lindgren

 15.10 – 15.40              Dr Nick Scott-Ram Open innovation and drug discovery: New approaches to market exclusivity

 15.40 – 16.10              Nick Maltby Creating an IP policy for Genomics England

 16.10 – 16.20              Short break

 16.20 – 16.50              Dr Lawrence Cullen Patentability of genetic sequences: What you can protect and why

 16.50 – 17.20              Dr Chris Moran  A charitable funder’s perspective on personalised medicine and the appropriate exploitation of IP

 

 Day 2 

 9.00 – 9.30                  Tea / coffee and pastries

 Panel 1: Patenting personalised medicine inventions Chair Professor Shobita Parathasaraty 

 9.30 – 10.00                Professor Siva Thambisetty Is personalised medicine real? Who is asking and why?

 10.00 – 10.30              Dr Katerina Sideri Patenting diagnostics and the future of personalised medicine: Private property and the romance of  the public domain

 10.30 – 10.50              Tea / coffee break

 Panel 2: Impact of patents on clinical practice Chair Dr Nina Hallowell

 10.50 – 11.20              Dr Naomi Hawkins Patents and non-invasive prenatal testing: Is there cause for concern?

 11.20 – 11.50              Dr Richard Reschen Commercialising university technologies for clinical benefit

 11.50 – 12.20              Dr John Liddicoat The phantom menace of gene patents arises?

 12.20 – 13.20              Lunch

 Panel 3: Genetic databases and clinical trial data Chair Professor Imogen Goold

 13.20 – 13.50              Dr Aisling McMahon Publicly funded biobanks and IP rights: Questions of access and public benefits

 13.50 – 14.20              Liam Curren Doing business with data 

 14.20 – 14.50              Professor Timo Minssen Clashes between clinical trials data transparency, IPRs, trade secrets and the legal protection    of personal data: What does it mean for precision medicine?

 14.50 – 15.10              Tea / coffee break

 Panel 4: Beyond patents Chair Professor Graham Dutfield

 15.10 – 15.40              Professor Isabelle Huys Personalised medicine and data sharing

 15.40 – 16.10              Professor Chas Bountra Competition and patents are slowing early drug discovery

 16.10 – 16.30              General discussion and close of the conference